A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer

NCT02595450 · clinicaltrials.gov ↗

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Erlotinib

Sponsor

Hoffmann-La Roche